Select Investor Type
Select the options below that best describe your investor status

Investor type

You will be able to select an investor type once a location has been selected.

Our disclaimer policy

By clicking 'Accept' you agree to our investing disclaimers.

Important Information

This website is intended for, and is relevant to, UK residents only and should not be relied upon by persons of any other jurisdiction.

By accepting where indicated, you hereby acknowledge, agree and respsent to Martin Currie that you are eligible by confirming that you are based in the UK and that you have read and understood the *Legal Regulatory Information* which applies to any investment in our products referred to in this website.

We do not give investment advice so you need to decide if an investment is suitable for you. If you are unsure whether to invest, you should contact a financial adviser.

Accept and Enter

Emerging market growth has the quality to perform

While growth has returned to favour in the US, value continues to lead in emerging markets. We seek to understand why this is and highlight what we think the next phase will bring.

Date published
11 Dec 2023
Tag

2023 has been another interesting year for global equity markets. Growth stocks have dominated markets and headlines. In US markets the impact has been clear – 2023 is the second-best year ever for growth versus value (31.7% performance gap between growth and value in the US as of 10 November 2023)1

Meanwhile in emerging markets, growth lags by over 6% in the same time period, marking the third consecutive calendar year where value has outpaced growth.2 Below we make the case why we believe it’s time for the market to reward quality growth stocks once again.

Why has value outperformed in emerging markets (EM), while growth leads in the US?

The three-year period ending 30 September 2023 has been the most difficult period for growth relative to value in the history of the emerging markets asset class. Despite having a significant amount of technology stocks, MSCI EM Growth has failed to outpace MSCI EM Value. The key reasons for MSCI EM Value’s outperformance are:

  • China’s heightened regulatory environment that began at the end of 2020 – this has led to outperformance of shorter duration, ‘cheap’ stocks
  • The aftermath of Russia/Ukraine conflict – this resulted in a severe rotation toward state-owned enterprises in the energy sector, which represents a much larger allocation in MSCI EM Value vs. Growth.3

In the US market, we have seen a very different setting. While the market sentiment towards China, a dominant component of the EM asset class, remains lukewarm, US investors have looked inward for growth. Key beneficiaries and, indeed, drivers of growth’s outperformance in the US include technology names, boosted by the optimism for innovation around artificial intelligence (AI).

Despite EM’s significant exposure to global leaders in technology, the weakness in the region overall and the focus on shorter duration value stocks has meant that their performance has not been commensurate with their US peers. But this cannot last.

The rotation has favoured stocks which are low quality. This means companies that typically lack robust balance sheets, strong business models, strong governance practices, effective management teams, or perhaps have unfavourable ownership structures or similar concerns. The share price performance of these companies does not align with the actual company performance and profitability. The market is due a correction which brings sentiment and company fundamentals back in sync.

  • The three-year period ending 30 September 2023 has been the most difficult period for growth relative to value in the history of the emerging markets asset class

The next phase for EM should favour growth

We believe that the persistent outperformance of low quality, value stocks within emerging markets is not sustainable indefinitely. The market must ultimately return to fundamentals. The fundamentals of companies which exhibit high quality and growth characteristics remain intact despite the market’s shift in style leadership. These companies are well positioned to withstand the uncertainties which remain around monetary policy, inflation and geopolitics, while benefiting from structural drivers of growth. We are especially excited about the following areas that we expect to play a key role in improving sentiment in EM in the coming months:

The opportunity set in EM is wide and deep, with the areas above only a snapshot of reasons to be excited. EM is home to innovators, global leaders, and beneficiaries of structural change. These companies pose a unique opportunity to investors in their unbounded potential to deliver sustainable, long-term growth at an attractive valuation. Time to strike while the iron is hot.

33146

China

While misconceptions have driven divergence between share prices and fundamentals, China continues to make progress on supporting domestic companies. Relations between the US and China are improving and companies are exhibiting a positive trend for stronger fundamentals.

33146

Inflation

Benign inflation combined with accommodative monetary policies in EM should be supportive of quality growth companies.

33146

Technology

We expect to see a rebound in technology earnings. EM is home to several world-leading technology companies which are positioned to benefit strongly from a rebound and which are crucial components of the global technology supply chain. These companies provide investors with a diverse range of opportunities, currently trading at materially lower valuations than US peers.4

33146

Valuations

Due to recent weakness in EM, companies are trading at attractive valuations compared to US peers4. Coupled with the expected return of a growth environment and the persistence of strong company fundamentals, this presents a great opportunity to add to positions, not exit them.

33146

India

India’s time has come. It is seizing its demographic dividend but importantly there is a rich opportunity set within the country - companies with long-term structural growth potential and well-regarded management teams. We expect these companies to continue to ride the wave of the Indian economic opportunity.

The opportunity set in EM is wide and deep, with the areas above only a snapshot of reasons to be excited. EM is home to innovators, global leaders, and beneficiaries of structural change. These companies pose a unique opportunity to investors in their unbounded potential to deliver sustainable, long-term growth at an attractive valuation. Time to strike while the iron is hot.


Important Information

This information is issued and approved by Martin Currie Investment Management Limited (‘MCIM’), authorised and regulated by the Financial Conduct Authority. It does not constitute investment advice. Market and currency movements may cause the capital value of shares, and the income from them, to fall as well as rise and you may get back less than you invested.

The information contained in this document has been compiled with considerable care to ensure its accuracy. However, no representation or warranty, express or implied, is made to its accuracy or completeness. Martin Currie has procured any research or analysis contained in this document for its own use. It is provided to you only incidentally and any opinions expressed are subject to change without notice.

The document does not form the basis of, nor should it be relied upon in connection with, any subsequent contract or agreement. It does not constitute, and may not be used for the purpose of, an offer or invitation to subscribe for or otherwise acquire shares in any of the products mentioned.

Past performance is not a guide to future returns.

The distribution of specific products is restricted in certain jurisdictions, investors should be aware of these restrictions before requesting further specific information.

The views expressed are opinions of the portfolio managers as of the date of this document and are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. These opinions are not intended to be a forecast of future events, research, a guarantee of future results or investment advice.

Risk warnings – Investors should also be aware of the following risk factors which may be applicable to the strategy shown in this document.

  • Investing in foreign markets introduces a risk where adverse movements in currency exchange rates could result in a decrease in the value of your investment.
  • This strategy may hold a limited number of investments. If one of these investments falls in value this can have a greater impact on the strategy’s value than if it held a larger number of investments.
  • Smaller companies may be riskier and their shares may be less liquid than larger companies, meaning that their share price may be more volatile.
  • Emerging markets or less developed countries may face more political, economic or structural challenges than developed countries. Accordingly, investment in emerging markets is generally characterised by higher levels of risk than investment in fully developed markets.
  • The strategy may invest in derivatives Index futures and FX forwards to obtain, increase or reduce exposure to underlying assets. The use of derivatives may result in greater fluctuations of returns due to the value of the derivative not moving in line with the underlying asset. Certain types of derivatives can be difficult to purchase or sell in certain market conditions.

For wholesale investors in Australia:

This material is provided on the basis that you are a wholesale client. MCIM has entered an Intermediary arrangement with Franklin Templeton Australia Limited (ABN 76 004 835 849) (AFSL No. 240827) (FTAL) to facilitate the provision of financial services by MCIM to wholesale investors in Australia. Franklin Templeton Australia Limited is part of Franklin Resources, Inc., and holds an Australian Financial Services Licence (AFSL No. AFSL240827) issued pursuant to the Corporations Act 2001.

For professional investors in Canada.

This material is intended for residents in, or incorporated in, Canada and are a Permitted Client for the purposes of MI 31-103. The information on this section of the website is not intended for use by any other person, including members of the public.

Martin Currie Inc, incorporated in New York with its registered office at 280 Park Avenue, New York, NY 10017 and having a UK branch registered in Scotland (no SF000300), Head office, 5 Morrison Street, 2nd floor, Edinburgh, EH3 8BH, Tel: +44 (0) 131 229 5252 Fax: +44 (0) 131 222 2532 www.martincurrie.com, operates under the International Adviser Exemption with the Ontario Securities Commission (‘OSC’) and is therefore currently not required to be registered as a portfolio manager for the purposes of MI 31-103. Martin Currie Inc. is also authorised by the UK Financial Conduct Authority.

For the avoidance of doubt, nothing excludes, limits or restricts our obligations to you under the UK Financial Services and Market Act 2000, National Instruments or any other applicable law or regulation.

The opinions and views in this website do not take into account your individual circumstances, objectives, or needs and are not intended to be recommendations of particular financial instruments or strategies to you.

This website does not identify all the risks (direct or indirect) or other considerations which might be material to you when entering any financial transaction. You should consult with your professional advisers before undertaking any investment activity. The information provided on this website should not be treated as advice or a recommendation to buy or sell any particular security or other investment. The information on this website has not been reviewed by any competent regulatory authority.

For professional investors:

In the People’s Republic of China:

This document does not constitute a public offer of the strategy, whether by sale or subscription, in the People’s Republic of China (the “PRC”). These strategies are not being offered or sold directly or indirectly in the PRC to or for the benefit of, legal or natural persons of the PRC.

Further, no legal or natural persons of the PRC may directly or indirectly purchase any of the strategy or any beneficial interest therein without obtaining all prior PRC’s governmental approvals that are required, whether statutorily or otherwise. Persons who come into possession of this document are required by the issuer and its representatives to observe these restrictions.

In Hong Kong:

The contents of this document have not been reviewed by any regulatory authority in Hong Kong.  You are advised to exercise caution in relation to the offer.  If you are in any doubt about any of the contents of this document, you should obtain independent professional advice.

In South Korea:

This document is for information purposes only. It is prepared and presented to provide an introduction to the business of MCIM and its related companies (collectively known as ‘Martin Currie’). This document does not constitute an offer to sell or a solicitation of any offer to invest in any security, fund or other vehicle managed or advised by Martin Currie.

None of the security(ies), fund(s) or vehicle(s) managed by or advised by Martin Currie are registered in South Korea under the Financial Investment Services and Capital Markets Act of Korea and accordingly, none of these instruments nor any interest therein may be offered, sold or delivered, or offered or sold to any person for re-offering or resale, directly or indirectly, in South Korea or to any resident of South Korea except pursuant to applicable laws and regulations of South Korea.

Martin Currie is not registered with or regulated by any regulatory authorities in South Korea.